Associations of rheumatoid arthritis, chronic lung diseases, and acute respiratory exacerbations among people who smoke in the prospective COPDGene study.
Sep 2026· Seminars in Arthritis & Rheumatism· Vol 81, pp.
153080
· 0 citations· 45 references
Medicine
TL;DR
In this large prospective study, people who smoke with RA were more likely to have ILA and BR than those without RA, but had similar prevalences of COPD and MP.
Abstract
Objective
To investigate associations between rheumatoid arthritis (RA), chronic lung diseases, and acute respiratory exacerbations.
Methods
Using the multicenter prospective COPDGene cohort of people who smoke (currently or previously), RA cases were identified using self-report and disease-modifying antirheumatic drug use. Interstitial lung abnormalities (ILA), bronchiectasis (BR), chronic obstructive pulmonary disease (COPD), and mucus plugging (MP) were identified via high-resolution computed tomography scans and spirometry and prevalences were compared among participants with and without RA. Risk of acute respiratory exacerbation over 10 years of follow-up was compared for those with and without RA and stratified by lung abnormality using multivariable Cox regression, accounting for competing mortality risk.
Results
We analyzed 76 RA cases (mean age 64.0 years, 67.1% female) and 8175 non-RA comparators (mean age 59.4 years, 46.2% female). RA cases vs non-RA comparators had higher prevalences of ILA (17.3%vs 7.1%, p = 0.0002) and BR (35.5%vs 24.6%, p = 0.027), but prevalences of COPD (46.1%vs 43.7%, p = 0.69) and MP (36.8%vs 29.6%, p = 0.17) were similar. RA was associated with higher risk of acute respiratory exacerbation than non-RA (adjusted HR 1.68, 95%CI 1.25 to 2.26), and those with RA and COPD had the highest risk (adjusted HR 3.57, 95%CI 2.15 to 5.94) compared to non-RA without COPD.
Conclusion
In this large prospective study, people who smoke with RA were more likely to have ILA and BR than those without RA, but had similar prevalences of COPD and MP. Participants with RA, particularly those with COPD, had higher risk of acute respiratory exacerbation.
The findings highlight the importance of systematic osteoporosis screening and monitoring as part of comprehensive COPD management, particularly in high-risk subgroups (older adults, females, and those with low BMI).
A. Lohana, U. Akbar, S. Chander et al.· Respiratory Medicine· 0 citations
Background/Objectives: Systemic inflammation is a widely recognised feature of chronic obstructive pulmonary disease (COPD). The combined contribution of acute-phase reactants and pro-inflammatory cytokines to disease severity and exacerbation risk remains incompletely understood. This study evaluated the associations...
Oana Maria Catană, Ramona Cioboată, D. Mitroi et al.· Diagnostics· 0 citations
A large prospective cohort study using UK Biobank data found that a higher FIB-4 index was independently associated with an increased risk of incident COPD.
RATIONALE
Platelet activation is elevated in chronic obstructive pulmonary disease (COPD) and associated with self-reported respiratory symptoms. Observational studies link the antiplatelet drug aspirin to lower exacerbation rates and fewer symptoms. However, it is unknown if platelet activation predicts incident respi...
A. Fawzy, N. Hansel, N. Putcha et al.· Annals of the American Thora...· 0 citations
Fibrotic interstitial lung disease (fILD) is often diagnosed late and can be difficult to recognise in people with common respiratory or cardiac long-term conditions. We examined whether baseline routine blood-test profiles and leucocyte telomere length (LTL) identified groups at higher risk of subsequent hospital-...
G. Lough, L. Wain, A. Meffen et al.· ERJ Open Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.